Skip to main content

stock

VRCA · Verrica Pharmaceuticals Inc.

What Verrica Pharmaceuticals Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live VRCA price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on VRCA.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
17,178,786 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-93.6%
Net
-102.9%

Returns

ROE
-724.3%
ROA
-86.6%

Health

Current ratio
1.5x
Debt/equity
—

Deep value

NCAV
$929,000
NCAV per share
$0.05
Price/NCAV
Locked
NNWC
-$10.95M
NNWC per share
-$0.64
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$5.86M—Gross profit: unreported by this company.-$13.10M-$13.15M
10-Q filed 2026-08-06
2026-03-31$5.02M—Gross profit: unreported by this company.-$9.71M-$9.68M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$5.09M—Gross profit: unreported by this company.-$7.19M-$8.09M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$14.34M—Gross profit: unreported by this company.$1.63M-$274,000
10-Q filed 2025-11-14
2025-06-30$12.70M—Gross profit: unreported by this company.$1.51M$204,000
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$3.44M—Gross profit: unreported by this company.-$8.13M-$9.74M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$344,000—Gross profit: unreported by this company.-$11.41M-$16.22M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30-$1.78M—Gross profit: unreported by this company.-$20.70M-$22.86M
10-Q filed 2025-11-14
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$36.02M
Equity
$4.31M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$35.58M-$12.19M-$17.90M-$17.63M
2024-12-31$7.57M-$65.92M-$76.60M-$60.95M
2023-12-31$5.12M-$65.76M-$67.00M-$38.94M
2022-12-31$9.03M-$21.30M-$24.49M-$18.95M
2021-12-31$12.00M-$30.91M-$35.08M-$28.46M
2020-12-31—-$40.18M-$42.69M-$31.68M
2019-12-31—-$30.08M-$28.21M-$28.09M
2018-12-31—-$21.88M-$20.65M-$18.65M
2017-12-31—-$4.46M-$4.46M—

Company filings

since Mon Dec 15 · 1 offering filing in 12 months

events

  • Results

    Results
    Aug 68-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Jun 98-K
  • Results

    Results
    May 128-K
  • Results

    Results
    Mar 118-K
  • Executive or director change

    Executive or director change
    Dec 308-K
  • Material agreement, Unregistered share sale, Other event

    Material agreementUnregistered share saleOther event
    11/24/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Zawitz David

    Chief Operating Officer

    Buy$29,880

    Aug 18, 5:00 PM ET

  • Rieger Jayson

    CEO and President, Director

    Buy$125,750

    Aug 18, 5:00 PM ET

  • Rosenberg Noah L.

    CMO

    Buy$30,610

    Aug 18, 5:00 PM ET

  • Kirby John J.

    Interim CFO

    Buy$24,650

    Aug 18, 5:00 PM ET

All insider trades for VRCA

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

News

Stories that named VRCA, and the market events around them.

Sign in to see this

Board

The VRCA board could not be loaded.

Retry the VRCA board

nakagai

Signals on VRCA come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the VRCA board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Verrica Pharmaceuticals Inc. (VRCA): SEC filings, financials and insider trades · Nakagai